KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Construction in Progress (2016 - 2017)

Regeneron Pharmaceuticals has reported Construction in Progress over the past 5 years, most recently at $408.9 million for Q4 2017.

  • Quarterly results put Construction in Progress at $408.9 million for Q4 2017, up 28.2% from a year ago — trailing twelve months through Dec 2017 was $408.9 million (up 28.2% YoY), and the annual figure for FY2017 was $408.9 million, up 28.2%.
  • Construction in Progress for Q4 2017 was $408.9 million at Regeneron Pharmaceuticals, up from $318.9 million in the prior quarter.
  • Over the last five years, Construction in Progress for REGN hit a ceiling of $579.8 million in Q4 2015 and a floor of $142.4 million in Q4 2013.
  • Median Construction in Progress over the past 5 years was $408.9 million (2017), compared with a mean of $384.4 million.
  • Biggest five-year swings in Construction in Progress: soared 231.69% in 2014 and later crashed 45.0% in 2016.
  • Regeneron Pharmaceuticals' Construction in Progress stood at $142.4 million in 2013, then soared by 231.69% to $472.2 million in 2014, then increased by 22.79% to $579.8 million in 2015, then crashed by 45.0% to $318.9 million in 2016, then rose by 28.2% to $408.9 million in 2017.
  • The last three reported values for Construction in Progress were $408.9 million (Q4 2017), $318.9 million (Q4 2016), and $579.8 million (Q4 2015) per Business Quant data.